|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/50 | |||
| A61K 38/17 | |||
| C07K 16/24 | |||
| A61K 38/27 | |||
| C07K 1/113 |
| (11) | Number of the document | 2600843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11810258.1 |
| Date of filing the European patent application | 2011-07-19 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/044485 |
| Date | 2011-07-19 |
| (87) | Number | WO 2012/012388 |
| Date | 2012-01-26 |
| (30) | Number | Date | Country code |
| 365728 P | 2010-07-19 | US |
| (72) |
SEEFELDT, Matthew, US
RANDOLPH, Theodore W., US
FRADKIN, Amber Haynes, US
CARPENTER, John, US
|
| (73) |
The Regents of the University of Colorado, A Body Corporate,
1800 Grant Street, 8th Floor, Denver, CO 80203,
US
Pressure BioSciences, Inc., 14 Norfolk Avenue, South Easton, MA 02375, US |
| (54) | THERAPEUTIC PROTEIN COMPOSITIONS HAVING REDUCED IMMUNOGENICITY AND/OR IMPROVED EFFICACY |
| THERAPEUTIC PROTEIN COMPOSITIONS HAVING REDUCED IMMUNOGENICITY AND/OR IMPROVED EFFICACY |